Skip to main content
logo
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.3450
-0.0181 (-4.98%)
Jun 24, 2026, 10:16 AM EDT - Market open

AIM ImmunoTech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.070.090.170.20.140.14
Revenue Growth (YoY)
-27.72%-48.23%-15.84%43.26%4.44%-17.18%
Cost of Revenue
0.120.130.030.04-0.85
Gross Profit
-0.05-0.040.140.160.14-0.72
Selling, General & Admin
6.927.713.7121.1413.078.67
Research & Development
3.333.926.210.946.997.67
Other Operating Expenses
-----1.78
Total Operating Expenses
10.2411.6219.9132.0820.0618.12
Operating Income
-10.27-11.66-19.77-31.92-19.92-18.84
Interest Income
3.183.185.191.070.63-
Interest Expense
-0.6-0.81-0.59---0.07
Other Non-Operating Income (Expense)
-3.99-4.67-2.161.89-0.15-0.22
Total Non-Operating Income (Expense)
-1.41-2.292.452.950.48-0.29
Pretax Income
-11.68-13.96-17.32-28.96-19.45-19.13
Net Income
-11.68-13.96-17.32-28.96-19.45-19.13
Net Income to Common
-13.28-13.96-17.32-28.96-19.45-19.13
Shares Outstanding (Basic)
321000
Shares Outstanding (Diluted)
321000
Shares Change (YoY)
312.23%188.95%15.18%1.12%1.49%48.67%
EPS (Basic)
-6.38-8.62-30.92-59.94-39.96-39.96
EPS (Diluted)
-6.38-8.62-30.92-59.94-39.96-39.96
Free Cash Flow
-11.32-10.96-14.91-21.27-16.19-14.01
Free Cash Flow Per Share
-4.48-6.77-26.61-43.73-33.67-29.56
Gross Margin
-67.12%-45.45%81.76%79.21%100.00%-529.63%
Operating Margin
-14069.90%-13254.50%-11630.60%-15800.00%-14129.80%-13954.10%
Profit Margin
-16000.00%-15861.40%-10188.20%-14337.60%-13790.80%-14168.10%
FCF Margin
-15500.00%-12451.10%-8768.24%-10528.20%-11485.10%-10374.80%
EBITDA
-10.11-11.45-19.53-31.68-19.67-18.06
EBITDA Margin
-13849.30%-13015.90%-11485.90%-15682.20%-13948.20%-13380.00%
EBIT
-10.27-11.66-19.77-31.92-19.92-18.84
EBIT Margin
-14069.90%-13254.50%-11630.60%-15800.00%-14129.80%-13954.10%
SEC Filings: 10-K · 10-Q